JOURNAL OF THROMBOSIS AND THROMBOLYSIS, cilt.22, sa.2, ss.103-110, 2006 (SCI-Expanded)
Background: Aspirin resistance may increase up to more then threefold the risk of major cardiovascular events (MACE) in patients with stable coronary artery disease.